These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology. Irimie A, Piciu D. Curr Radiopharm; 2017 Nov 10; 10(3):146-154. PubMed ID: 28814251 [Abstract] [Full Text] [Related]
27. Amiodarone and the thyroid. Jabrocka-Hybel A, Bednarczuk T, Bartalena L, Pach D, Ruchała M, Kamiński G, Kostecka-Matyja M, Hubalewska-Dydejczyk A. Endokrynol Pol; 2015 Nov 10; 66(2):176-86. PubMed ID: 25931048 [Abstract] [Full Text] [Related]
28. Iodine kinetic studies during amiodarone treatment. Rao RH, McCready VR, Spathis GS. J Clin Endocrinol Metab; 1986 Mar 10; 62(3):563-8. PubMed ID: 3944239 [Abstract] [Full Text] [Related]
29. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. Trifănescu R, Fica S, Barbu C, Vârtej I, Ursu H, Bunghez R, Coculescu M. Rom J Intern Med; 2004 Mar 10; 42(3):595-605. PubMed ID: 16366133 [Abstract] [Full Text] [Related]
32. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C, Bambini G, Safran M, Braverman LE, Pinchera A. Clin Endocrinol (Oxf); 1987 Feb 10; 26(2):227-37. PubMed ID: 3665117 [Abstract] [Full Text] [Related]
33. Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. Borowski GD, Garofano CD, Rose LI, Spielman SR, Rotmensch HR, Greenspan AM, Horowitz LN. Am J Med; 1985 Mar 10; 78(3):443-50. PubMed ID: 3976702 [Abstract] [Full Text] [Related]
34. [Thyrotoxicosis, then hypothyroidism caused by iodine overload (amiodarone) associated with neuropathy. Failure of plasma exchange]. Patte D, Léger FA, Savoie JC, Ménage JJ, Samson Y, Nivet M, Goulon M. Ann Med Interne (Paris); 1983 Mar 10; 134(1):31-4. PubMed ID: 6305250 [Abstract] [Full Text] [Related]
35. Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. Stäubli M, Studer H. Klin Wochenschr; 1985 Feb 15; 63(4):168-75. PubMed ID: 3920432 [Abstract] [Full Text] [Related]
36. [Usefulness of thyroid scintigraphy in the therapeutic management of amiodarone-induced hyperthyroidism]. Pacheco Capote C, Mena Bares LM, Benítez Velazco A, Louhibi Rubio L, Contreras Puertas PI, Maza Muret FR, Latre Romero JM. Rev Esp Med Nucl; 2007 Feb 15; 26(5):270-6. PubMed ID: 17910835 [Abstract] [Full Text] [Related]
37. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H. J Clin Endocrinol Metab; 1984 Apr 15; 58(4):676-80. PubMed ID: 6421866 [Abstract] [Full Text] [Related]
38. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake. Reinhardt MJ, Joe A, von Mallek D, Zimmerlin M, Manka-Waluch A, Palmedo H, Krause TM. Eur J Nucl Med Mol Imaging; 2002 Apr 15; 29(4):480-5. PubMed ID: 11914885 [Abstract] [Full Text] [Related]
39. The effects of amiodarone on the thyroid. Martino E, Bartalena L, Bogazzi F, Braverman LE. Endocr Rev; 2001 Apr 15; 22(2):240-54. PubMed ID: 11294826 [Abstract] [Full Text] [Related]
40. Goitre and thyroid dysfunction during chronic amiodarone treatment. Eason RJ, Croxson MS, Lim TM, Evans MC, Cooper GJ. N Z Med J; 1984 Apr 11; 97(753):216-9. PubMed ID: 6585712 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]